QuidelOrtho Corporation
QDEL
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
QuidelOrtho Corporation se zaměřuje na vývoj a výrobu diagnostických testovacích technologií napříč kontinuitou potřeb testování zdravotní péče. Společnost působí prostřednictvím obchodních jednotek Labs, Transfusion Medicine, Point-of-Care a Molecular Diagnostics. Obchodní jednotka Labs poskytuje laboratorní nástroje a testy klinické chemie, které měří cílové chemické látky v tělesných tekutinách pro hodnocení zdraví a klinické řízení pacientů; laboratorní nástroje a testy imunoanalýzy, které měří bílkoviny, jelikož působí jako antigeny v šíření onemocnění, protilátky v imunitní reakci vyvolané nemocí nebo markery správné funkce a zdraví orgánů; testuje produkty pro detekci a sledování progrese onemocnění napříč spektrem terapeutických oblastí; a specializovaná diagnostická řešení. Obchodní jednotka pro léčivé přípravky pro transfuze nabízí imunohematologické nástroje a testy používané k typizaci krve, aby byla zajištěna kompatibilita mezi pacienty a dárci při transfuzích krve, a dále nástroje a testy pro screening krve a plazmy na infekční onemocnění. Obchodní jednotka Point-of-Care poskytuje testy, které poskytují rychlé výsledky napříč kontinuálním nastavením point-of-care. Obchodní jednotka Molekulární diagnostika nabízí termoklery polymerázové řetězové reakce a analyzátory a amplifikační systémy. Společnost prodává své výrobky přímo koncovým uživatelům prostřednictvím přímého prodeje a prostřednictvím sítě distributorů pro profesionální použití v lékařských ordinacích, nemocnicích, klinických laboratořích, referenčních laboratořích, klinikách urgentní péče, univerzitách, maloobchodních klinikách, lékárnách, wellness screeningových centrech, krevních bankách a dárcovských centrech, jakož i pro individuální, neprofesionální a volně prodejné použití. Působí v Severní Americe, Evropě, na Blízkém východě, v Africe, Číně a mezinárodně. Společnost byla založena v roce 1979 a sídlí v kalifornském San Diegu.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
6600
Založení
1991-02-01
Podobné společnosti
$ 86.11
- $ 0.71
$ 27.68
+ $ 0.24
$ 32.41
+ $ 0.36
$ 31.28
+ $ 1.01
$ 35.12
+ $ 2.28
$ 26.00
- $ 1.80
$ 11.02
- $ 0.16
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2,730.2 | 2,730.2 | 2,782.9 | 2,997.8 | 3,266.0 | 1,698.6 | 1,661.7 | 534.9 | 522.3 | 277.7 | 191.6 | 196.1 | 182.6 | 175.4 | 155.7 | 158.6 | 113.3 | |
| Cost of Revenues | 1,456.0 | 1,456.0 | 1,496.4 | 1,503.4 | 1,330.0 | 427.7 | 312.8 | 214.1 | 206.6 | 121.6 | 73.4 | 71.7 | 74.2 | 67.0 | 61.3 | 62.9 | 52.6 | |
| Gross Profit | 1,274.2 | 1,274.2 | 1,286.5 | 1,494.4 | 1,936.0 | 1,270.9 | 1,348.9 | 320.8 | 315.7 | 156.1 | 118.2 | 124.4 | 108.4 | 108.4 | 94.5 | 95.7 | 60.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 723.6 | 699.9 | 613.9 | 692.8 | 707.8 | 727.1 | 637.0 | 711.0 | 742.6 | 744.0 | |
| Cost of Revenues | 403.2 | 364.3 | 339.0 | 349.5 | 381.7 | 374.8 | 361.0 | 378.9 | 422.6 | 375.9 | |
| Gross Profit | 320.4 | 335.6 | 274.9 | 343.3 | 326.1 | 352.3 | 276.0 | 332.1 | 320.0 | 368.1 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 246.8 | 190.5 | 95.7 | 84.3 | 52.6 | 51.6 | 33.6 | 38.7 | 35.5 | 37.9 | 34.2 | 27.7 | 26.3 | 24.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 763.2 | 621.0 | 259.6 | 200.5 | 163.9 | 153.9 | 96.4 | 74.9 | 77.3 | 67.3 | 60.1 | 51.0 | 48.5 | 42.4 | |
| Depreciation & Amortization | 442.0 | 442.0 | 453.4 | 457.2 | 260.4 | 9.6 | 3.7 | 51.8 | 46.3 | 30.8 | 9.1 | 8.9 | 8.8 | 8.2 | 6.9 | 7.1 | 6.7 | |
| Total Operating Expenses | 2,193.4 | 2,193.4 | 3,247.4 | 1,355.3 | 956.3 | 355.3 | 284.8 | 216.4 | 205.6 | 130.1 | 122.6 | 121.7 | 114.1 | 102.4 | 85.6 | 82.0 | 73.7 | |
| Operating Income | -919.2 | -919.2 | -1,960.9 | 139.1 | 843.7 | 906.1 | 1,060.3 | 52.6 | 95.9 | 9.6 | -4.4 | 2.7 | -9.2 | 4.2 | 8.8 | 13.7 | -15.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 59.3 | 62.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 187.6 | 194.1 | ||
| Depreciation & Amortization | 112.5 | 112.1 | 110.3 | 107.1 | 109.3 | 113.1 | 116.1 | 114.9 | 115.4 | 113.1 | ||
| Total Operating Expenses | 386.7 | 1,040.4 | 455.6 | 310.7 | 426.5 | 337.3 | 393.5 | 2,090.1 | 246.9 | 315.3 | ||
| Operating Income | -66.3 | -704.8 | -180.7 | 32.6 | -100.4 | 15.0 | -117.5 | -1,758.0 | 40.1 | 26.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.2 | 0.0 | 0.0 | 2.2 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | |
| Interest Expense | 177.6 | 177.6 | 188.3 | 178.9 | 75.7 | 5.7 | 9.6 | 14.8 | 24.3 | 17.6 | 11.8 | 12.0 | 1.8 | 0.8 | 1.2 | 2.1 | 2.3 | |
| Other Expense | -188.5 | -188.5 | -170.6 | -168.2 | -107.8 | -5.7 | -20.0 | 24.6 | -22.5 | -16.5 | -11.8 | -12.0 | -3.6 | -1.8 | 0.0 | -0.4 | -2.3 | |
| IBT | -1,107.7 | -1,107.7 | -2,131.5 | -29.1 | 735.9 | 900.4 | 1,040.3 | 77.2 | 63.4 | -8.0 | -16.2 | -9.3 | -11.0 | 3.4 | 7.6 | 11.5 | -17.4 | |
| Income Tax Expense | 24.1 | 24.1 | -79.5 | -19.0 | 187.2 | 196.1 | 230.0 | 4.3 | -10.8 | 0.1 | -2.4 | -3.2 | -3.9 | -4.0 | 2.6 | 3.9 | -6.1 | |
| Net Income | -1,131.8 | -1,131.8 | -2,052.0 | -10.1 | 548.7 | 704.2 | 810.3 | 72.9 | 74.2 | -8.2 | -13.8 | -6.1 | -7.1 | 7.4 | 5.0 | 7.6 | -11.3 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.1 | 0.0 | 3.1 | 0.0 | 0.0 | 0.4 | 0.5 | 0.0 | 0.6 | 1.3 | ||
| Interest Expense | 43.1 | 46.1 | 46.1 | 42.3 | 44.7 | 49.5 | 47.8 | 31.8 | 36.7 | 37.7 | ||
| Other Expense | -46.1 | -52.1 | -48.9 | -41.4 | -40.5 | -43.8 | -45.4 | -40.9 | -49.3 | -41.8 | ||
| IBT | -112.4 | -756.9 | -229.6 | -8.8 | -140.9 | -28.8 | -162.9 | -1,798.9 | -9.2 | -15.5 | ||
| Income Tax Expense | 18.3 | -23.9 | 25.8 | 3.9 | 37.5 | -8.9 | -15.2 | -92.9 | -16.2 | -2.8 | ||
| Net Income | -130.7 | -733.0 | -255.4 | -12.7 | -178.4 | -19.9 | -147.7 | -1,706.0 | 7.0 | -12.7 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.15 | $9.66 | $16.74 | $19.24 | $1.78 | $1.86 | $-0.24 | $-0.42 | $-0.18 | $-0.21 | $0.22 | $0.15 | $0.23 | $-0.39 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.15 | $9.56 | $16.43 | $18.60 | $1.73 | $1.74 | $-0.24 | $-0.42 | $-0.18 | $-0.21 | $0.21 | $0.15 | $0.23 | $-0.39 | |
| Shares Outstanding | 67.8 | 67.8 | 67.2 | 66.8 | 57.4 | 42.9 | 43.6 | 42.0 | 39.9 | 33.7 | 32.7 | 33.8 | 33.7 | 34.9 | 33.7 | 32.9 | 28.6 | |
| Diluted Shares Outstanding | 67.8 | 67.8 | 67.2 | 66.8 | 57.4 | 42.9 | 43.6 | 43.1 | 42.6 | 33.7 | 32.7 | 34.1 | 34.5 | 34.9 | 33.7 | 33.3 | 28.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $-0.19 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $-0.19 | ||
| Shares Outstanding | 67.8 | 68.0 | 67.7 | 67.5 | 67.2 | 67.3 | 67.1 | 66.9 | 66.9 | 66.9 | ||
| Diluted Shares Outstanding | 67.8 | 68.0 | 67.7 | 67.5 | 67.2 | 67.3 | 67.1 | 66.9 | 67.3 | 66.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 107.0 | 98.3 | 118.9 | 292.9 | 802.8 | 489.9 | 52.8 | 43.7 | 36.1 | 169.5 | 191.5 | 204.0 | 9.4 | 17.0 | 61.3 | 6.8 | |
| Short Term Investments | 0.0 | 0.0 | 48.4 | 52.1 | 25.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 107.0 | 98.3 | 167.3 | 345.0 | 802.8 | 489.9 | 52.8 | 43.7 | 36.1 | 169.5 | 191.5 | 204.0 | 9.4 | 17.0 | 61.3 | 6.8 | |
| Accounts Receivable | 497.3 | 451.3 | 488.4 | 453.9 | 393.8 | 529.2 | 104.9 | 76.9 | 67.0 | 25.0 | 18.4 | 34.5 | 29.9 | 32.6 | 14.6 | 13.5 | |
| Inventory | 602.0 | 533.7 | 577.8 | 524.1 | 198.8 | 113.8 | 58.1 | 67.4 | 67.1 | 26.0 | 26.4 | 24.8 | 27.6 | 15.5 | 14.7 | 17.7 | |
| Other Current Assets | 135.0 | 135.6 | 77.0 | 252.1 | 4.6 | 2.2 | 1.9 | 0.9 | 161.0 | 4.9 | 4.4 | 15.0 | 12.7 | 11.9 | 13.9 | 9.7 | |
| Total Current Assets | 1,341.3 | 1,218.9 | 1,310.5 | 1,575.1 | 1,440.3 | 1,142.4 | 222.2 | 193.4 | 331.2 | 225.4 | 240.7 | 275.1 | 78.6 | 74.8 | 90.6 | 56.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 98.1 | 151.7 | 127.1 | 98.3 | 143.7 | 107.0 | 78.5 | 118.9 | 149.3 | 178.6 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 48.4 | 43.9 | 45.1 | |
| Total Cash & ST Investments | 98.1 | 151.7 | 127.1 | 98.3 | 143.7 | 107.0 | 78.5 | 167.3 | 193.2 | 223.7 | |
| Accounts Receivable | 513.0 | 396.9 | 437.0 | 451.3 | 518.5 | 472.9 | 476.1 | 488.4 | 520.2 | 426.6 | |
| Inventory | 613.8 | 578.7 | 563.2 | 533.7 | 577.0 | 602.0 | 583.1 | 577.8 | 551.7 | 542.2 | |
| Other Current Assets | 141.8 | 154.2 | 130.9 | 135.6 | 173.4 | 159.4 | 74.7 | 77.0 | 106.2 | 236.2 | |
| Total Current Assets | 1,366.7 | 1,281.5 | 1,258.2 | 1,218.9 | 1,412.6 | 1,341.3 | 1,212.4 | 1,310.5 | 1,371.3 | 1,308.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1,503.9 | 1,548.9 | 1,613.4 | 1,520.0 | 476.8 | 211.0 | 171.9 | 73.9 | 61.6 | 50.9 | 52.5 | 49.2 | 48.1 | 34.2 | 28.1 | 31.8 | |
| Goodwill | 732.5 | 649.5 | 2,492.0 | 2,476.8 | 337.0 | 337.0 | 337.0 | 337.0 | 337.0 | 83.8 | 80.7 | 80.7 | 80.8 | 71.0 | 71.0 | 71.0 | |
| Intangible Assets | 2,836.0 | 2,735.6 | 2,934.3 | 3,123.8 | 98.7 | 122.4 | 148.1 | 175.0 | 203.8 | 27.6 | 31.8 | 41.9 | 62.3 | 60.3 | 73.8 | 53.7 | |
| Long-Term Investments | 0.5 | 21.7 | 7.4 | 21.0 | 37.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 250.3 | 249.0 | 179.6 | 122.7 | 19.6 | 13.5 | 7.1 | 4.8 | 1.6 | 0.5 | 0.7 | 4.6 | 1.8 | 1.8 | 15.3 | 2.1 | |
| Total Long-Term Assets | 5,347.9 | 5,204.7 | 7,252.6 | 7,280.7 | 990.1 | 728.8 | 688.6 | 613.0 | 604.0 | 162.9 | 165.8 | 176.4 | 192.9 | 167.3 | 188.3 | 158.6 | |
| Total Assets | 6,689.2 | 6,423.6 | 8,563.1 | 8,855.8 | 2,430.4 | 1,871.2 | 910.9 | 806.4 | 935.3 | 388.3 | 406.5 | 451.6 | 271.4 | 241.6 | 278.9 | 214.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1,480.3 | 1,471.8 | 1,564.4 | 1,548.9 | 1,539.2 | 1,503.9 | 1,621.8 | 1,613.4 | 1,541.6 | 1,553.6 | |
| Goodwill | 0.0 | 711.1 | 670.9 | 649.5 | 770.6 | 732.5 | 734.8 | 2,492.0 | 2,442.9 | 2,470.9 | |
| Intangible Assets | 2,608.0 | 2,660.5 | 2,697.9 | 2,735.6 | 2,795.9 | 2,836.0 | 2,887.3 | 2,934.3 | 2,976.5 | 3,035.7 | |
| Long-Term Investments | 12.9 | 0.0 | 0.0 | 21.7 | 0.0 | 0.0 | 0.5 | 8.0 | 11.9 | 24.7 | |
| Other Long-Term Assets | 207.2 | 254.2 | 270.2 | 249.0 | 257.1 | 250.8 | 221.6 | 179.0 | 179.2 | 141.2 | |
| Total Long-Term Assets | 4,308.4 | 5,097.6 | 5,203.4 | 5,204.7 | 5,388.5 | 5,347.9 | 5,490.9 | 7,252.6 | 7,167.8 | 7,242.2 | |
| Total Assets | 5,675.1 | 6,379.1 | 6,461.6 | 6,423.6 | 6,801.1 | 6,689.2 | 6,703.3 | 8,563.1 | 8,539.1 | 8,550.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 237.4 | 246.0 | 294.8 | 283.3 | 101.5 | 86.3 | 26.7 | 25.2 | 27.3 | 16.0 | 8.7 | 12.4 | 7.0 | 7.9 | 5.0 | 4.7 | |
| Short-Term Debt | 385.9 | 372.9 | 166.5 | 207.5 | 10.0 | 7.8 | 19.1 | 54.4 | 20.2 | 0.1 | 0.6 | 0.5 | 0.4 | 0.4 | 0.3 | 0.3 | |
| Other Current Liabilities | 269.0 | 341.0 | 324.6 | 439.8 | 210.1 | 239.1 | 78.6 | 16.6 | 18.5 | 7.6 | 17.9 | 17.1 | 14.6 | 12.8 | 2.5 | 5.5 | |
| Current Liabilities | 932.4 | 998.8 | 833.8 | 1,007.0 | 323.5 | 337.0 | 125.9 | 159.7 | 128.3 | 33.6 | 30.8 | 36.4 | 24.0 | 23.2 | 45.6 | 15.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 213.7 | 218.8 | 230.9 | 246.0 | 247.2 | 237.4 | 249.6 | 294.8 | 253.0 | 225.9 | |
| Short-Term Debt | 191.8 | 564.2 | 425.0 | 372.9 | 405.1 | 385.9 | 189.9 | 166.5 | 219.3 | 233.7 | |
| Other Current Liabilities | 327.4 | 271.4 | 329.5 | 341.0 | 309.4 | 243.9 | 296.9 | 324.6 | 385.9 | 328.3 | |
| Current Liabilities | 767.9 | 1,142.1 | 1,047.2 | 998.8 | 1,027.3 | 932.4 | 779.8 | 833.8 | 860.0 | 790.0 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2,207.1 | 2,308.5 | 2,447.2 | 2,617.2 | 128.6 | 100.7 | 93.2 | 53.2 | 377.3 | 148.3 | 147.3 | 146.7 | 5.1 | 10.6 | 47.9 | 79.8 | |
| Capital Leases | 177.8 | 167.2 | 199.5 | 186.4 | 138.6 | 108.5 | 99.6 | 0.0 | 0.0 | 4.1 | 4.6 | 5.1 | 5.6 | 5.9 | 6.3 | 6.6 | |
| Def. Tax Liability | 127.9 | 76.5 | 192.2 | 213.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 2.0 | 14.9 | 6.3 | 3.3 | 7.0 | 2.3 | |
| Total Liabilities | 3,515.7 | 3,439.1 | 3,557.2 | 3,921.2 | 501.0 | 538.5 | 351.0 | 380.8 | 708.1 | 187.6 | 187.8 | 206.5 | 47.8 | 41.9 | 93.5 | 102.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2,652.0 | 2,228.5 | 2,269.2 | 2,308.5 | 2,350.6 | 2,384.9 | 2,422.8 | 2,447.2 | 2,450.5 | 2,489.7 | |
| Capital Leases | 155.5 | 186.4 | 194.5 | 167.2 | 205.3 | 207.2 | 182.0 | 173.2 | 175.9 | 181.2 | |
| Def. Tax Liability | 80.1 | 82.8 | 78.2 | 76.5 | 117.2 | 127.9 | 125.6 | 192.2 | 196.5 | 199.6 | |
| Total Liabilities | 3,638.7 | 3,586.4 | 3,464.4 | 3,439.1 | 3,614.4 | 3,515.7 | 3,395.6 | 3,557.2 | 3,572.4 | 3,547.8 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 334.1 | 135.8 | 2,187.8 | 2,197.9 | 1,649.2 | 945.0 | 134.7 | 61.8 | -12.4 | -4.3 | 9.6 | 15.6 | 22.7 | 15.3 | 10.3 | 2.7 | |
| Comprehensive Income | -24.6 | -36.2 | -30.0 | -67.6 | 0.4 | -0.4 | -0.5 | -0.1 | -82.7 | -0.1 | 0.0 | 0.0 | 0.0 | -50.9 | -45.9 | -42.6 | |
| Total Common Equity | 3,173.5 | 2,984.5 | 5,005.9 | 4,934.6 | 1,929.4 | 1,332.7 | 559.8 | 425.6 | 227.1 | 200.6 | 218.7 | 245.0 | 223.5 | 199.8 | 185.4 | 112.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -865.3 | -132.3 | 123.1 | 135.8 | 314.2 | 334.1 | 481.8 | 2,187.8 | 2,180.8 | 2,193.5 | |
| Comprehensive Income | -19.7 | 16.2 | -23.8 | -36.2 | -3.5 | -24.6 | -26.2 | -30.0 | -53.2 | -16.3 | |
| Total Common Equity | 2,036.4 | 2,792.7 | 2,997.2 | 2,984.5 | 3,186.7 | 3,173.5 | 3,307.7 | 5,005.9 | 4,966.7 | 5,002.5 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 2,770.8 | 2,681.4 | 2,614.1 | 2,824.7 | 138.6 | 108.5 | 112.3 | 107.6 | 397.4 | 148.4 | 147.9 | 147.2 | 5.6 | 10.9 | 47.9 | 79.8 | |
| Book Value | 3,173.5 | 2,984.5 | 5,005.9 | 4,934.6 | 1,929.4 | 1,332.7 | 559.8 | 425.6 | 227.1 | 200.6 | 218.7 | 245.0 | 223.5 | 199.8 | 185.4 | 112.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,036.4 | 2,792.7 | 2,997.2 | 2,984.5 | 3,186.7 | 3,173.5 | 3,307.7 | 5,005.9 | 4,966.7 | 5,002.5 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1,859.4 | -1,131.8 | -2,052.0 | -10.1 | 548.7 | 704.2 | 810.3 | 72.9 | 74.2 | -8.2 | -13.8 | -6.1 | -7.1 | 7.4 | 5.0 | 7.6 | -11.3 | |
| Depreciation & Amortization | 459.5 | 442.0 | 453.4 | 457.2 | 283.6 | 54.4 | 49.1 | 51.8 | 46.3 | 30.8 | 22.8 | 23.4 | 28.4 | 24.7 | 23.3 | 17.8 | 12.3 | |
| Stock-Based Compensation | 46.6 | 0.0 | 42.1 | 51.6 | 48.4 | 25.4 | 21.0 | 13.3 | 11.7 | 9.1 | 8.0 | 7.4 | 6.7 | 8.8 | 6.6 | 7.5 | 5.2 | |
| Change Working Capital | -329.9 | -125.8 | -158.7 | -194.9 | -53.2 | -2.8 | -251.1 | -15.2 | -2.3 | -23.8 | -7.5 | 10.6 | 7.1 | -11.2 | -15.7 | 10.8 | -17.5 | |
| Change In Accounts Receivable | -30.3 | -117.5 | 5.4 | 160.0 | 150.2 | 118.9 | -402.1 | -36.1 | 8.2 | -42.1 | -6.3 | 16.1 | -4.5 | 2.9 | -17.9 | 8.9 | 3.1 | |
| Change In Accounts Payable | 14.1 | 40.0 | -23.4 | 3.0 | 23.5 | 10.4 | 52.2 | 2.4 | -0.3 | 13.0 | 4.3 | -3.1 | 4.4 | -0.7 | 1.5 | -1.0 | -2.6 | |
| Change In Inventories | -220.8 | -148.3 | -134.1 | -211.6 | -116.9 | -85.0 | -54.9 | 9.1 | -4.0 | 0.4 | 0.9 | -1.6 | 2.9 | -12.0 | -1.1 | 3.1 | 2.4 | |
| Other Non-cash Items | 2,302.6 | 914.5 | 1,897.5 | -23.6 | 57.8 | 0.0 | 20.6 | 13.5 | 27.0 | 19.5 | 5.0 | 5.0 | 3.3 | -2.1 | -1.0 | 2.0 | 1.3 | |
| Cash from Operations | 23.3 | 0.0 | 0.0 | 280.2 | 885.3 | 805.9 | 629.8 | 134.5 | 136.3 | 27.7 | 11.8 | 36.3 | 35.7 | 25.7 | 19.6 | 47.0 | -10.3 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -130.7 | -733.0 | -255.4 | -12.7 | -178.4 | -19.9 | -147.7 | -1,706.0 | 7.0 | -12.7 | |
| Depreciation & Amortization | 112.5 | 112.1 | 110.3 | 107.1 | 109.3 | 113.1 | 116.1 | 114.9 | 115.4 | 113.1 | |
| Stock-Based Compensation | 0.0 | 10.7 | 12.8 | 11.6 | 9.6 | 12.3 | 11.2 | 9.1 | 12.3 | 14.1 | |
| Change Working Capital | 129.1 | -134.8 | -74.7 | -45.4 | -16.3 | 9.1 | -129.7 | -86.3 | -45.2 | -68.7 | |
| Change In Accounts Receivable | -28.8 | -113.4 | 22.5 | 2.2 | -2.2 | -16.6 | -2.2 | 26.4 | 35.9 | -90.4 | |
| Change In Accounts Payable | 55.9 | 7.6 | -22.2 | -1.3 | 0.0 | 7.0 | -13.2 | -10.7 | 9.3 | 28.7 | |
| Change In Inventories | -6.6 | -39.1 | -49.5 | -53.1 | -23.2 | -15.7 | -57.5 | -37.7 | -65.6 | -60.0 | |
| Other Non-cash Items | 14.7 | 700.5 | 160.2 | 5.1 | 139.5 | -70.3 | 51.9 | 1,741.5 | 7.1 | -1.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 80.4 | 41.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -193.4 | -188.2 | -195.1 | -209.3 | -140.9 | -292.7 | -64.9 | -27.2 | -31.7 | -17.5 | -11.9 | -17.0 | -11.2 | -22.5 | -27.7 | -20.8 | -10.5 | |
| Acquisitions | -85.8 | 6.5 | 0.0 | 0.0 | -1,511.4 | 0.0 | 0.0 | 0.0 | 0.0 | -414.2 | -5.1 | 0.0 | 0.0 | -11.4 | -1.0 | 0.0 | -128.1 | |
| Investments | -16.7 | 0.0 | -7.2 | -60.1 | -63.7 | -67.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.0 | |
| Sales of Investment | 87.5 | 0.0 | 63.1 | 78.3 | 53.4 | 3.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.0 | |
| Other Investing Activities | 76.5 | 0.0 | 0.0 | 3.5 | 18.4 | 36.9 | 1.6 | 0.0 | 146.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 3.1 | |
| Cash from Investing | -131.9 | 0.0 | 0.0 | -187.6 | -1,644.2 | -319.5 | -63.3 | -27.2 | 115.0 | -431.8 | -17.0 | -17.0 | -11.2 | -33.9 | -28.6 | -20.8 | -134.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -45.3 | -49.2 | 6.5 | 10.1 | -47.2 | -46.5 | -35.3 | -66.1 | -48.6 | -43.4 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -85.8 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.2 | -9.5 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 63.1 | 10.0 | 14.4 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 78.8 | 7.7 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -55.1 | -21.3 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -279.6 | 0.0 | 0.0 | -226.4 | -2,388.3 | -0.3 | -44.0 | -53.6 | -201.9 | -0.1 | -5.0 | -0.5 | -0.4 | -5.4 | -38.8 | -30.3 | -3.2 | |
| Debt Issued | 353.3 | 2,681.4 | 67.3 | 15.8 | 5,074.4 | 30.4 | 40.2 | 58.3 | -87.9 | 249.1 | 5.5 | 1.2 | 142.1 | 0.0 | 1.8 | -1.5 | 83.0 | |
| Issuance of Common Stock | 8.9 | 0.0 | 0.0 | 11.6 | 26.4 | 7.6 | 9.6 | 14.8 | 17.0 | 25.4 | 8.6 | 2.9 | 4.8 | 7.9 | 4.7 | 59.2 | 1.2 | |
| Repurchase of Common Stock | -13.5 | 0.0 | 0.0 | -7.2 | -74.3 | -103.4 | -47.9 | -10.7 | -4.3 | -0.5 | -20.2 | -30.9 | -2.0 | -2.2 | -3.4 | -0.6 | -9.2 | |
| Dividends Paid | -13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -255.0 | 0.0 | 0.0 | -172.5 | 0.0 | 0.0 | 0.0 | -75.0 | |
| Other Financing Activities | 7.6 | 0.0 | 0.0 | -43.8 | 2,688.2 | -77.0 | -48.0 | -48.8 | -54.8 | 500.8 | -0.2 | -0.2 | 338.2 | 1.4 | 0.1 | 0.0 | 148.9 | |
| Cash from Financing | 37.5 | 0.0 | 0.0 | -265.8 | 252.0 | -173.2 | -130.3 | -98.3 | -244.1 | 270.6 | -16.8 | -28.7 | 168.1 | 1.8 | -37.5 | 28.3 | 62.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -53.6 | -49.0 | |
| Debt Issued | 2,843.8 | 51.1 | 98.5 | 12.8 | -74.3 | -15.1 | 158.1 | -1.4 | 24.2 | -4.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.5 | 0.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | 0.0 | -7.2 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | -0.5 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -57.8 | -48.7 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -72.0 | 71.3 | -21.0 | -174.4 | -508.9 | 312.8 | 437.2 | 9.1 | 7.6 | -133.4 | -22.0 | -9.4 | 192.5 | -6.5 | -46.5 | 54.5 | -82.2 | |
| Closing Cash Balance | 107.0 | 169.8 | 98.5 | 119.5 | 293.9 | 802.8 | 489.9 | 52.8 | 43.7 | 36.1 | 169.5 | 191.5 | 200.9 | 8.4 | 14.9 | 61.3 | 6.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 71.7 | -53.6 | 24.5 | 28.7 | -45.5 | 36.5 | 28.5 | -40.4 | -30.4 | -29.7 | |
| Closing Cash Balance | 169.8 | 98.1 | 151.7 | 127.2 | 98.5 | 144.0 | 107.0 | 78.5 | 118.9 | 149.9 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -170.1 | -83.0 | -112.1 | 70.9 | 744.4 | 513.1 | 564.8 | 107.3 | 104.7 | 10.2 | -0.1 | 19.3 | 24.4 | 3.2 | -8.1 | 26.2 | -20.8 | |
| Real Free Cash Flow | -216.7 | -83.0 | -154.2 | 19.3 | 696.0 | 487.7 | 543.8 | 94.0 | 92.9 | 1.1 | -8.1 | 11.9 | 17.7 | -5.6 | -14.7 | 18.7 | -25.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 86.6 | -94.7 | -40.3 | 75.7 | 16.5 | 71.4 | -133.2 | -66.8 | 31.8 | -1.9 | |
| Real Free Cash Flow | 86.6 | -105.4 | -53.1 | 64.1 | 6.9 | 59.1 | -144.4 | -75.9 | 19.5 | -16.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -0.9 | -258.7 | 1703.4 |
| P/S | 0.4 | 4.3 | 67.9 |
| P/B | 0.5 | 3.8 | 25.8 |
| P/FCF | -132.5 | 27.5 | 396.3 |
| Market cap | $1.4 | $2.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 21.9 % | 0 % |
| Debt to Income | -251.3 % | -3367.6 % | 0 % |
| Debt to Free cash flow | -36459 % | 296.7 % | 0 % |
| Interest expense percentage | -19.3 % | 31.5 % | 38.7 % |
| Current ratio | 1.8 | 53.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -55.6 % | 2.8 % | 0 % |
| ROA | -19.9 % | 3.3 % | 0 % |
| CapEx to Revenue | 2.9 % | 8.2 % | 10.6 % |
| RaD to Revenue | 0 % | 13.1 % | 0 % |
| ROEM | 413,666.7 | 34364 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 46.7 % | 60.1 % | 79.8 % |
| Operating margin | -33.7 % | 10.1 % | 29.6 % |
| Net margin | -41.5 % | 1.3 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1.3 % | 0 % |
| Dividend payout percentage | 0 % | -91.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 67.8 mil | 43.4 mil |
| Employee count | 6.6 tis | 6.8 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
